Session » Health Services Research Poster II

Date: Sunday, November 13, 2022

Time: 9:00AM-10:30AM

Meeting: ACR Convergence 2022

9:00AM-10:30AM: Abstract Number: 0751

Accessing Telehealth and In-Person Healthcare During the COVID-19 Pandemic: Experiences of Individuals with Rheumatoid Arthritis

9:00AM-10:30AM: Abstract Number: 0732

Application of Natural Language Processing to Identify Varicella Zoster Infection in Clinical Notes

9:00AM-10:30AM: Abstract Number: 0734

Comfort Levels and Practice Patterns for Osteoporosis-Related Care Among Persons Living with HIV in Peru: A National Physician Survey

9:00AM-10:30AM: Abstract Number: 0724

Development of a Global Strategy to Strengthen Health Systems for Prevention and Management of Musculoskeletal Health

9:00AM-10:30AM: Abstract Number: 0736

Educational Needs Among Health Professionals in Rheumatology: Low Awareness of EULAR Offerings and Unfamiliarity with Course Content as a Major Barrier – a EULAR Funded European Survey

9:00AM-10:30AM: Abstract Number: 0739

Effect of Tailored Self-Management Interventions on Health Outcomes in Individuals with Chronic Musculoskeletal Conditions

9:00AM-10:30AM: Abstract Number: 0735

Facilitators and Barriers to Weekly Monitoring of Disease Activity with Electronic Patient Reported Outcomes: A Focus Group Study of Patients with Inflammatory Arthritis

9:00AM-10:30AM: Abstract Number: 0743

Home-Based Telehealth in Rheumatology: A Systematic Review & Narrative Synthesis

9:00AM-10:30AM: Abstract Number: 0730

Improving Mental Health Services in Children and Adolescents with Systemic Lupus Erythematosus by Establishing a Mental Health Care Navigator

9:00AM-10:30AM: Abstract Number: 0738

Integrated Behavioral Health Services for Patients with Chronic Musculoskeletal Pain: Rheumatology Provider Perspectives

9:00AM-10:30AM: Abstract Number: 0748

Mapping Long COVID-19 Patient Journeys for Rheumatic Disease Patients

9:00AM-10:30AM: Abstract Number: 0733

Median Patient Global Assessment Varies Far More According to FAST4 (fibromyalgia Assessment Screening Tool) and MDS2 (MDHAQ Depression Screen) on a Single MDHAQ (multidimensional Health Assessment Questionnaire) Than According to Primary Diagnosis

9:00AM-10:30AM: Abstract Number: 0747

Methotrexate and Hydroxychloroquine Used as Single Agent May Diminish Breakthrough Infection After COVID-19 Vaccination

9:00AM-10:30AM: Abstract Number: 0726

Optimizing Laboratory Medication Safety Monitoring in Patients with JIA to Advance Value-based Care

9:00AM-10:30AM: Abstract Number: 0742

Patient Factors Influencing Recruitment in a Telemedicine Randomized Clinical Trial

9:00AM-10:30AM: Abstract Number: 0741

Prescribing Patterns of SGLT2 Inhibitors for Patients with Autoimmune Rheumatic Disease

9:00AM-10:30AM: Abstract Number: 0727

Primary Prevention of Fractures in Osteoporotic Patients in a Southern California Academic Health System

9:00AM-10:30AM: Abstract Number: 0750

Quality Improvement Project to Increase the Rate of Vaccination with Pneumococcal Vaccines (PCV13 prime-PPSV23 Boost Strategy) Among Adult Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) Within Nationwide Health Organization

9:00AM-10:30AM: Abstract Number: 0728

Racial Disparities in Pain: Severity, Interference with Function, and Response to Guided Imagery

9:00AM-10:30AM: Abstract Number: 0740

Real-World Demographics, Clinical Characteristics, and Treatment Patterns of Patients Treated with Emapalumab for Secondary Hemophagocytic Lymphohistiocytosis in the United States: The REAL-HLH Study

9:00AM-10:30AM: Abstract Number: 0731

Remote Monitoring of Chronic Inflammatory Musculoskeletal Diseases– Results of the Digireuma Feasibility Study

9:00AM-10:30AM: Abstract Number: 0737

Rheumatologic Rashes in Different Skin Types and Confidence in Diagnosis Among Internal Medicine Residents in a New York City Hospital

9:00AM-10:30AM: Abstract Number: 0746

Telemedicine for Follow-up of Lupus Nephritis in the Covid-19 Outbreak: A Pragmatic Randomized Controlled Trial

9:00AM-10:30AM: Abstract Number: 0729

Understanding the Practice and Process of Patient Reported Outcome Measures Collection in North American Pediatric Rheumatology Clinics: A Survey of the Pediatric Rheumatology-Care and Outcomes Improvement Network

9:00AM-10:30AM: Abstract Number: 0744

University of North Carolina and Piedmont Health Collaborative Tele-Rheumatology Project to Optimize Rural Health Specialty Access

9:00AM-10:30AM: Abstract Number: 0745

Use of Telemedicine in Patients with Systemic Lupus Erythematosus in a Publicly Funded Hospital System

9:00AM-10:30AM: Abstract Number: 0725

Utility of Repeat Extractable Nuclear Antigen Antibody Testing- a Retrospective Audit

9:00AM-10:30AM: Abstract Number: 0749

Virtual Care in Rheumatology Ambulatory Clinics During the COVID-19 Pandemic: Patient/Family and Healthcare Provider Perspectives and Experiences

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].